Ligand Enters Commercial License and Supply Agreements for Captisol-enabled trametinib
Ligand Pharmaceuticals announces it has entered into global license and supply agreements with Novartis for the development and commercialization of a Captisol-enabled oral liquid…
Read More...
Read More...